(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | 17.11%636.16M | -8.27%1.22B | 51.24%543.21M | 131.25%360.32M | 643.80%1.33B | --359.17M | --155.81M | 274.06%178.26M | --47.66M |
Operating income | 17.11%636.16M | -8.27%1.22B | 51.24%543.21M | 131.25%360.32M | 643.80%1.33B | 359.17M | 155.81M | 274.06%178.26M | 47.66M |
Cost of sales | -17.75%-591.31M | 9.87%-1.1B | -49.43%-502.17M | -135.12%-337.28M | -759.03%-1.22B | ---336.07M | ---143.45M | -271.73%-141.48M | ---38.06M |
Operating expenses | -17.75%-591.31M | 9.87%-1.1B | -49.43%-502.17M | -135.12%-337.28M | -759.03%-1.22B | -336.07M | -143.45M | -271.73%-141.48M | -38.06M |
Gross profit | 9.29%44.85M | 9.39%120.95M | 77.64%41.04M | 86.42%23.04M | 200.61%110.57M | 23.1M | 12.36M | 283.32%36.78M | 9.6M |
Selling expenses | 14.85%-11.55M | -16.60%-32.28M | 15.72%-13.57M | 27.20%-5.93M | -194.38%-27.68M | ---16.1M | ---8.15M | -208.70%-9.4M | ---3.05M |
Administrative expenses | 39.55%-23.2M | -102.13%-83.92M | -170.24%-38.38M | -258.42%-20.46M | -39.72%-41.52M | ---14.2M | ---5.71M | -245.89%-29.72M | ---8.59M |
Research and development expenses | 4.23%-99.59M | -108.20%-216.62M | -123.97%-103.99M | -143.65%-48.46M | -89.36%-104.05M | ---46.43M | ---19.89M | -24.48%-54.95M | ---44.14M |
Impairment and provision | -156.81%-1.7M | 143.07%1.6M | 303.20%2.99M | 252.74%2.9M | -155.82%-3.72M | ---1.47M | --821K | -1,514.44%-1.45M | ---90K |
-Other impairment is provision | -156.81%-1.7M | 143.07%1.6M | 303.20%2.99M | 252.74%2.9M | -155.82%-3.72M | ---1.47M | --821K | -1,514.44%-1.45M | ---90K |
Special items of operating profit | -185.73%-8.88M | 228.12%13.39M | 11,118.09%10.36M | 4,380.11%7.96M | -51.11%4.08M | ---94K | ---186K | 150.83%8.35M | --3.33M |
Operating profit | 1.46%-100.06M | -215.97%-196.87M | -83.99%-101.55M | -97.35%-40.96M | -23.66%-62.31M | -55.19M | -20.75M | -17.33%-50.39M | -42.94M |
Financing income | 79.70%3.66M | 3,009.00%3.11M | 2,292.94%2.03M | 1,626.67%518K | 6.38%100K | --85K | --30K | 944.44%94K | --9K |
Financing cost | -840.77%-2.19M | 99.52%-1.35M | 99.91%-233K | 99.76%-190K | 32.31%-280.17M | ---245.33M | ---79.64M | -3,699.75%-413.91M | ---10.89M |
Earning before tax | 1.15%-98.6M | 43.01%-195.11M | 66.80%-99.75M | 59.52%-40.63M | 26.24%-342.38M | -300.43M | -100.36M | -762.39%-464.2M | -53.83M |
Tax | ---29K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
After-tax profit from continuing operations | 1.12%-98.63M | 43.01%-195.11M | 66.80%-99.75M | 59.52%-40.63M | 26.24%-342.38M | -300.43M | -100.36M | -762.39%-464.2M | -53.83M |
Earning after tax | 1.12%-98.63M | 43.01%-195.11M | 66.80%-99.75M | 59.52%-40.63M | 26.24%-342.38M | -300.43M | -100.36M | -762.39%-464.2M | -53.83M |
Profit attributable to shareholders | 1.12%-98.63M | 43.01%-195.11M | 66.80%-99.75M | 59.52%-40.63M | 26.24%-342.38M | -300.43M | -100.36M | -762.39%-464.2M | -53.83M |
Basic earnings per share | 10.20%-0.44 | 46.33%-0.95 | 69.57%-0.49 | 63.64%-0.2 | 36.79%-1.77 | -1.61 | -0.55 | -656.76%-2.8 | -0.37 |
Diluted earnings per share | 10.20%-0.44 | 46.33%-0.95 | 69.57%-0.49 | 63.64%-0.2 | 36.79%-1.77 | -1.61 | -0.55 | -656.76%-2.8 | -0.37 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data